Description

7-(Dimethylamino)-1,3-Dihydro-1-Methyl-5-Phenyl-2H-1,4-Benzodiazepine-2-One is a high-purity benzodiazepine derivative of significant interest in advanced chemical synthesis. This compound matters as a critical pharmaceutical intermediate and a versatile building block for research into bioactive molecules. It is primarily needed by manufacturers and R&D teams in the pharmaceutical, agrochemical, and fine chemical industries for developing new active ingredients and complex organic compounds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel benzodiazepine-based active pharmaceutical ingredients (APIs) and other therapeutic agents.
• Research & Development: Used as a standard or building block in medicinal chemistry for drug discovery programs targeting the central nervous system.
• Fine Chemical Synthesis: Acts as a versatile reagent for constructing complex heterocyclic structures in custom synthesis and process development.
• Agrochemical Research: Employed in the development of new crop protection agents and pesticides that utilize benzodiazepine scaffolds.
• Academic Research: Utilized in universities and research institutes for studying chemical reactions, molecular properties, and biological activity.
• Chemical Reference Standard: Supplied as a high-purity material for analytical method development, validation, and quality control laboratories.

Basic Information

Product Name	7-(Dimethylamino)-1,3-Dihydro-1-Methyl-5-Phenyl-2H-1,4-Benzodiazepine-2-One
CAS No.	2891-09-0
Molecular Formula	C18H19N3O
Molecular Weight	293.37 g/mol
Synonyms	7-(Dimethylamino)-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1-Methyl-7-(dimethylamino)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Ro 5-2807; Ro 5-2807/1; 2891-09-0; 7-Dimethylamino-1-methyl-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one; 7-(N,N-Dimethylamino)-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
EINECS	Contact for details

Quality Control

Our 7-(Dimethylamino)-1,3-Dihydro-1-Methyl-5-Phenyl-2H-1,4-Benzodiazepine-2-One is produced under strict quality management systems. Every batch undergoes rigorous analytical testing to ensure it meets the high-purity standards required for pharmaceutical and research applications. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.